Theranostics News and Research

RSS

New method may offer effective treatment for pancreatic cancer with fewer side effects

Pancreatic cancer is one of the leading causes of cancer-related deaths worldwide. Patients with pancreatic cancer often receive chemotherapy or radiation therapy, which are not always effective and can have toxic side effects.

21 Oct 2019

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy.

9 Oct 2019

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, can be detected by medical imaging and has staying power in the bloodstream.

19 Aug 2019

Ultrasensitive method for direct detection of circulating tumor cells in blood

Tumor cells circulating in blood are markers for the early detection and prognosis of cancer. However, detection of these cells is challenging because of their scarcity.

8 Aug 2019

Clinical study demonstrates potential of regenerative therapy for hypoplastic left heart syndrome

A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery.

24 Jul 2019

Researchers develop new nanotheranostic system that solves many problems

Theranostics is an emerging field of medicine whose name is a combination of "therapeutics" and "diagnostics".

9 Jul 2019

Fecal miRNAs could provide clues to early inflammation found in chronic gut conditions

Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.

28 Jun 2019

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.

26 Jun 2019

Newly developed melanin nanoparticles could slow tumor growth

The dark skin pigment melanin protects us from the sun's damaging rays by absorbing light energy and converting it to heat.

5 Apr 2019

Researchers show potential of biomimicry to grow prevascularized tissues for cardiac patches

A team led by Feng Zhao, associate professor of biomedical engineering at Michigan Technological University, recently published two new papers on best practices in engineering prevascularized tissues.

29 Mar 2019

Newly engineered nanoscale protein micelles can be tracked by MRI

A team of researchers from New York University has engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging.

21 Mar 2019

New approach to creating 'theranostics' for targeting specific tumors, diseases

A City of Hope scientist and his colleagues have developed a user-friendly approach to creating "theranostics" - therapy combined with diagnostics - that target specific tumors and diseases.

6 Mar 2019

RWTH Aachen chooses MILabs’ hybrid OI/CT system to enhance molecular imaging research

RWTH Aachen University have chosen the MILabs high-resolution CT to further enhance its world-leading molecular imaging research.

From MILabs 26 Feb 2019

New findings could provide novel approach to target and destroy cancer cells

An unexpected finding in pre-clinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.

11 Feb 2019

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

4 Dec 2018

New approach targets matrix surrounding neurons to protect neurons after stroke

To protect neurons and limit the damage after a stroke, researchers from the CNRS, the University of Caen-Normandie, University Paris-Est Créteil, and the company OTR3 have pursued an innovative path: targeting the matrix that surrounds and supports brain cells.

15 Nov 2018